| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 5 Feb 2026 | 22 Jan 2026 |
| Quarterly Results National Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2025. The Board Meeting to be held on 28/01/2026 Stands Cancelled. (As per BSE Announcement dated on: 27.01.2026) National Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31, 2025. (As per BSE Announcement dated on: 02.02.2026) This is to inform you that the Board of Directors of National Peroxide Limited at their meeting held today i.e., on February 05, 2026, had inter-alia considered and approved the following: 1. Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025. 2. Based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company approved the appointment of the Company Secretary & Compliance Officer. (As per BSE announcement dated on : 05.02.2026) | ||
| Board Meeting | 18 Dec 2025 | 18 Dec 2025 |
| The Company hereby informs that the Board in its meeting held on December 18, 2025, have appointed Interim Chief Financial Officer of the Company effective December 18, 2025 | ||
| Board Meeting | 3 Nov 2025 | 29 Oct 2025 |
| National Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 inter alia to consider and approve unaudited financial results for the quarter and half year ended September 30 2025 Outcome of Board Meeting of National Peroxide Limited (As per BSE Announcement dated on: 03.11.2025) | ||
| Board Meeting | 29 Jul 2025 | 24 Jul 2025 |
| National Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 inter alia to consider and approve the Unaudited Financial Results for the quarter ended June 30 2025. The Board in its meeting held on July 29, 2025, approved the unaudited financial results for the quarter ended June 30, 2025. The Board in its meeting held on July 29, 2025, had approved the unaudited financial results for the quarter ended June 30, 2025. (As Per BSE Announcement Dated on: 29.07.2025) | ||
| Board Meeting | 6 May 2025 | 1 May 2025 |
| National Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 inter alia to consider and approve Audited Financial results for the quarter and year ended March 31 2025 and to recommend dividend if any for the financial year ended March 31 2025. Board meeting outcome for approval of Audited Financial results for the Quarter and year ended March 31, 2025 (As Per Bse Announcement Dated on :06.05.2025) Corrigendum to the outcome of Board Meeting (As Per BSE Announcement Dated on :15.05.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
